Gain Therapeutics Ratios (2020-2025) | GANX

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin (Quarter) -8,735.52%-8,455.03%-11,850.15%-18,131.62%-46,440.84%-4,353.30%-17,035.72%8,411.38%-7,267.84%-5,337.72%-9,279.80%
EBIT Margin (Quarter) -7,676.61%-8,355.01%-12,232.51%-17,678.47%-46,819.42%-4,306.17%-16,953.46%-8,829.61%-7,306.75%-5,442.98%-9,477.68%
EBITDA Margin (Quarter) -7,676.61%-8,355.01%-12,232.51%-17,678.47%-46,819.42%-4,306.17%-16,953.46%-8,829.61%-7,306.75%-5,442.98%-9,477.68%
Operating Margin (Quarter) -7,676.61%-8,355.01%-12,232.51%-17,678.47%-46,819.42%-4,306.17%-16,953.46%-8,829.61%-7,306.75%-5,442.98%-9,477.68%
Net Margin (Quarter) -8,755.70%-8,526.00%-11,863.37%-18,116.65%-46,506.87%-4,357.78%-17,054.43%8,434.07%-7,271.57%-5,347.33%-9,310.11%
FCF Margin (Quarter) -11,354.91%-6,655.39%-11,296.80%-14,473.88%-53,869.71%-3,969.23%-8,134.80%-11,440.14%-5,455.31%-5,358.05%-7,663.03%
Efficiency
Assets Average (Quarter) 28.82M46.70M43.96M40.77M38.29M34.74M30.11M26.21M22.71M19.79M16.18M16.35M16.59M16.89M16.78M13.24M11.87M10.73M10.40M
Equity Average (Quarter) -0.20M3.68M7.02M25.33M42.93M39.47M36.18M33.32M29.42M24.84M20.77M17.01M13.12M9.21M9.95M10.61M10.21M10.35M8.12M6.56M4.74M4.80M
Invested Capital (Quarter) 0.07M-0.48M7.83M6.22M44.51M41.45M37.63M34.92M31.91M27.10M22.76M18.99M15.25M11.20M7.44M12.70M8.75M11.90M9.03M7.45M5.89M3.82M6.03M
Asset Utilization Ratio (Quarter) 0.000.000.000.000.000.010.010.010.010.000.000.00
Leverage & Solvency
Debt to Equity (Quarter) 0.120.020.020.020.020.020.020.030.030.040.050.070.050.060.040.060.060.070.120.07
Debt Ratio (Quarter) 0.080.020.020.020.020.020.020.020.030.030.030.040.030.030.030.030.040.040.050.04
Equity Ratio (Quarter) 0.650.930.910.880.890.850.850.800.780.710.610.520.680.590.610.620.610.500.380.54
Valuation
Enterprise Value (Quarter) -7.50M-46.60M-43.17M-40.98M-36.88M-34.34M-24.25M-22.73M-20.14M-17.82M-16.19M-12.23M-16.79M-12.66M-16.90M-12.05M-10.39M-9.10M-6.69M-8.81M
Return Ratios
Return on Sales (Quarter) -87.56%-85.26%-118.63%-181.17%-465.07%-43.58%-170.54%84.34%-72.72%-53.47%-55.83%-1.78%-93.10%-85.47%-88.37%-403.54%
Return on Capital Employed (Quarter) -0.21%-0.19%-0.30%-0.36%-0.43%-0.52%-0.64%-0.80%-1.12%-1.57%-2.15%-1.95%-1.85%-2.11%-1.76%-2.18%-2.97%-3.12%-2.82%
Return on Invested Capital (Quarter) -0.50%-0.21%-0.20%-0.31%-0.38%-0.44%-0.55%-0.66%-1.36%-1.21%-1.73%-2.48%-2.22%-2.00%-2.12%-2.05%-2.54%-3.14%-3.70%-3.82%
Return on Assets (Quarter) -0.19%-0.18%-0.28%-0.19%-0.22%-0.29%-0.33%-0.01%-0.09%-0.24%-0.30%-1.36%-1.27%-1.28%-1.27%-1.54%-1.76%-1.73%-1.86%
Return on Equity (Quarter) -0.51%-0.21%-0.20%-0.31%-0.21%-0.25%-0.34%-0.40%-0.01%-0.12%-0.36%-0.53%-2.24%-1.99%-2.11%-2.07%-2.51%-3.19%-3.92%-4.04%